Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin

doi:10.3748/wjg.v12.i42.6771

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3229)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

330

HTML

2689

Figures (1-5)

210

Sum=3229

Nov 14, 2006 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Nov 14, 2006; 12(42): 6771-6778
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6771

Full Size Figure Download Figure

Figure 3 BrdU incorporation in MH cells treated with 1 nmol/L HTI-286. Decrease in S phase was observed as BrdU incorporation decreased significantly (P = 0.024) in MH cells compared to the untreated cells when exposed to 1 nmol/L HTI-286 for two cell doubling times.

Citation: Vashist YK, Tiffon C, Stoupis C, Redaelli CA. Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin. World J Gastroenterol 2006; 12(42): 6771-6778
URL: https://www.wjgnet.com/1007-9327/full/v12/i42/6771.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i42.6771